Browse Guides  internal medicine  allergy and immunology

Anaphylaxis

Prevalence
Causes
Clinical features
Differential diagnosis
Investigations
Therapy
Prevention
Prognosis
Investigations

Consider
  • mast cell tryptase (within 6 hrs of the episode) d

 

Consider referral to a specialist clinic for further investigations, including
  • skin prick testing d
  • IgE levels d
  • Intradermal testing for drug induced episodes d

Why?

Mast cell tryptase can rule out anaphylaxis and intradermal testing can help rule it in

Patient Target Disorder and
Reference Standard
Diagnostic Test LR+
(95% CI)
Post-test Probability LR-
(95% CI)
Post-test Probability
suspected anaphylaxis d
(pre-test probability: 64%)
Drug-induced anaphylaxis (sole agent, positive passive transfer or subsequent anaesthesia)
 
intradermal testing 22
(3.2 to 150)
98% 0.24
(0.17 to 0.35)
30%
suspected anaphylaxis d
(pre-test probability: 39%)
Problematic subsequent general anaesthetic
 
skin-prick or intradermal testing 1.2
(1.1 to 1.4)
44% 0.18
(0.04 to 0.76)
11%
suspected anaphylaxis d

(pre-test probability: 44%)
Anaphylaxis (radioimmunoassay or intradermal testing)
 
Mast cell tryptase >3mcg/L 4.9
(3.6 to 6.6)
79% 0.066
(0.032 to 0.14)
5%
 
 

Expiry date: September 2004
Levels of Evidence used in grading these guides

Authors   M   Bennett , RS   Phillips
Reviewer   M   Daniel
CAT Writers   CM   Ball , M   Bennett